Minerva

Minerva

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7114.1028 (Published 18 October 1997) Cite this as: BMJ 1997;315:1028

Primary angioplasty for acute myocardial infarction gives better results than thrombolytic treatment, and a group of articles in the current issue of Heart (1997;78:323-36) presents strong arguments for immediate angioplasty to be made more widely available. Patients who should be given priority for angioplasty include those with cardiogenic shock and those with contraindications to thrombolytic treatment. As with medical thrombolysis, time is of the essence.

Data from 10 AIDS reference centres in France looking after 7749 patients have shown that since the introduction of protease inhibitors and highly active antiretroviral treatment (HAART) the costs of treatment have risen but expenditure on admission to hospital has fallen (AIDS 1997;11:F101-5). The cost of the drugs has risen by around $12 per patient each month, but the total costs of the health care have fallen by $101 per patient each month.

Outbreaks of Lassa fever continue to occur in Nigeria, and a recent study there has found that 12.3% of 552 health workers tested had antibodies to the Lassa virus (Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91:379-81). Rates were highest in locations where there had been recent outbreaks. The authors comment that even simple barrier techniques are little used in primary and secondary health centres.

Cocaine is dangerous stuff: the Journal of Neurology, Neurosurgery …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe